Home › Research › Tau biomarkers
Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease
Schubert CR, Paulsen AJ, Pinto AA, Chappell RJ, Chen Y, Ferrucci L, Hancock LM, Cruickshanks KJ et al.. Alzheimer disease and associated disorders, 2023-09-13
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Aim To determine whether exposure to neurotoxins in midlife is associated with changes in blood-based biomarkers of neurodegeneration and Alzheimer disease pathology. Methods Blood cadmium, lead, neurofilament light (NfL) chain, total tau (TTau), and amyloid beta (Aβ) 40 and Aβ42 concentrations were measured in 1516 participants in the Beaver Dam Offspring Study. Linear mixed-effect models were used to determine associations between baseline cadmium and lead levels and baseline NfL, TTau, and Aβ42/Aβ40, and 10-year change in concentrations using repeated measures of these biomarkers as the outcome.
What this study adds
Evidence grade: Low
The record lists 1,516 participants. In 1516 participants, higher blood cadmium and lead levels in women were associated with changes in blood markers of neurodegeneration over 10 years. Reported effect size: 0.2%; 0.9%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Schubert, C. R., Paulsen, A. J., Pinto, A. A., Chappell, R. J., Chen, Y., Ferrucci, L., et al. (2023). Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease. Alzheimer disease and associated disorders. https://doi.org/10.1097/wad.0000000000000579
Vancouver
Schubert CR, Paulsen AJ, Pinto AA, Chappell RJ, Chen Y, Ferrucci L, et al. Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease. Alzheimer disease and associated disorders. 2023. doi:10.1097/wad.0000000000000579. PMID: 37698523.
BibTeX
@article{schubert2023-37698523,
author = {Schubert, C. R. and Paulsen, A. J. and Pinto, A. A. and Chappell, R. J. and Chen, Y. and Ferrucci, L. and Hancock, L. M. and Cruickshanks, K. J. and others},
title = {{Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease}},
journal = {Alzheimer disease and associated disorders},
year = {2023},
doi = {10.1097/wad.0000000000000579},
pmid = {37698523},
url = {https://doi.org/10.1097/wad.0000000000000579}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Methods Blood cadmium, lead, neurofilament light (NfL) chain, total tau (TTau), and amyloid beta (Aβ) 40 and Aβ42 concentrations were measured in 1516 participants in the Beaver Dam Offspring Study.
- Linear mixed-effect models were used to determine associations between baseline cadmium and lead levels and baseline NfL, TTau, and Aβ42/Aβ40, and 10-year change in concentrations using repeated measures of these biomarkers as the outcome.
- Results In women, higher cadmium and lead levels were associated with higher baseline TTau concentrations.
- A higher baseline cadmium level was associated with lower baseline Aβ42/Aβ40 in both men and women.
Why it matters
In 1516 participants, higher blood cadmium and lead levels in women were associated with changes in blood markers of neurodegeneration over 10 years. This links exposure to markers but does not show that avoiding these metals prevents Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants1,516
- Effect size0.2%; 0.9%
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer disease and associated disorders) |
| Journal's citation record | 1 / 4 | Alzheimer Disease & Associated Disorders: journal h-index 131 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,516 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 9 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.8 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 1 / 6 | Cited 0.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Natascha Merten: h-index 15 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | National Institutes of Health: institution h-index 2,723 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37698523) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1097/wad.0000000000000579
- PubMed: 37698523
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.